Prelude Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-208,664
| Closed | -$3.28M | – | 2179 |
|
|
2022
Q2 | $3.28M | Buy |
208,664
+64,468
| +45% | +$984K | 0.09% | 171 |
|
|
2022
Q1 | $2.19M | Buy |
144,196
+106,057
| +278% | +$1.62M | 0.06% | 309 |
|
|
2021
Q4 | $586K | Buy |
+38,139
| New | +$502K | 0.02% | 919 |
|
|
2021
Q3 | – | Sell |
-111,400
| Closed | -$1.14M | – | 2159 |
|
|
2021
Q2 | $1.14M | Buy |
111,400
+51,600
| +86% | +$545K | 0.03% | 543 |
|
|
2021
Q1 | $715K | Buy |
+59,800
| New | +$678K | 0.02% | 739 |
|
|
2020
Q4 | – | Sell |
-2,283
| Closed | -$14K | – | 2202 |
|
|
2020
Q3 | $14K | Buy |
2,283
+400
| +21% | +$3.05K | ﹤0.01% | 1407 |
|
|
2020
Q2 | $17K | Buy |
1,883
+550
| +41% | +$4.74K | ﹤0.01% | 1431 |
|
|
2020
Q1 | $10K | Sell |
1,333
-1,767
| -57% | -$13.1K | ﹤0.01% | 1138 |
|
|
2019
Q4 | $27K | Sell |
3,100
-14,300
| -82% | -$107K | ﹤0.01% | 1528 |
|
|
2019
Q3 | $106K | Buy |
+17,400
| New | +$97.8K | ﹤0.01% | 938 |
|
|
2019
Q2 | – | Sell |
-11,000
| Closed | -$69K | – | 2276 |
|
|
2019
Q1 | $69K | Sell |
11,000
-24,518
| -69% | -$172K | ﹤0.01% | 1047 |
|
|
2018
Q4 | $230K | Buy |
+35,518
| New | +$272K | 0.02% | 678 |
|
|
2018
Q2 | – | Sell |
-92,449
| Closed | -$633K | – | 2040 |
|
|
2018
Q1 | $633K | Buy |
92,449
+52,655
| +132% | +$334K | 0.05% | 386 |
|
|
2017
Q4 | $262K | Buy |
39,794
+5,363
| +16% | +$32.8K | 0.02% | 556 |
|
|
2017
Q3 | $191K | Sell |
34,431
-14,667
| -30% | -$99K | 0.02% | 670 |
|
|
2017
Q2 | $379K | Buy |
49,098
+45,998
| +1,484% | +$389K | 0.04% | 396 |
|
|
2017
Q1 | $28K | Buy |
3,100
+500
| +19% | +$5.21K | ﹤0.01% | 1222 |
|
|
2016
Q4 | $28K | Buy |
2,600
+2,100
| +420% | +$28K | ﹤0.01% | 1248 |
|
|
2016
Q3 | $8K | Sell |
500
-10,000
| -95% | -$141K | ﹤0.01% | 1459 |
|
|
2016
Q2 | $100K | Buy |
+10,500
| New | +$114K | 0.01% | 767 |
|
|
2015
Q4 | – | Sell |
-19,500
| Closed | -$133K | – | 1759 |
|
|
2015
Q3 | $133K | Buy |
19,500
+11,200
| +135% | +$86.7K | 0.02% | 751 |
|
|
2015
Q2 | $76K | Sell |
8,300
-464
| -5% | -$3.52K | 0.01% | 995 |
|
|
2015
Q1 | $59K | Buy |
+8,764
| New | +$35.3K | 0.01% | 1219 |
|
Other funds holding NPTN
Prelude Capital Management's NPTN Position: Q3 2022 in Review
Prelude Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 208,664 shares — an estimated $3.28M sold.
Prelude Capital Management first reported a position in NPTN in Q1 2015 and held it in 23 quarters. The position peaked at $3.28M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- Prelude Capital Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- Prelude Capital Management sold 208,664 NEOPHOTONICS CORP shares in Q3 2022, an estimated $3.28M.
- Prelude Capital Management first reported a position in NEOPHOTONICS CORP in Q1 2015 and held it in 23 quarters.
- Prelude Capital Management's NEOPHOTONICS CORP position peaked at $3.28M in Q2 2022.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on Prelude Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.